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11. ABSTRACT
Digoxin-like immunoreactivity has been
reported in plasma of neonates, patients with renal
failure, liver failure and pregnancy. Thus the assay of
digoxin level in these groups may not accurately
reflect the true therapeutic level. The cross
reactivity can be due to either the non-specificity of
the antibody used in the assay or the existence of
endogenous compound(s) with similar structure to
digoxin. In addition, digoxin-like immunoreactive
substance (DLIS) has also been implicated as potential
endogenous inhibitor of [Na+, K+] -ATPase.
Newborn infants and pregnant women are known
to have high level of steroid hormones and their
intermediates in circulation. Because of structural
similarities between steroid hormones and digoxin, the
correlation of steroid concentrations and digoxin-like
immunoreactivity in cord blood was examined. Cross-
reactivity of progesterone, oestradiol, dehydro-
epiandrosterone sulphate (DHEAS), androstenedione, 17a-
hydroxyprogesterone (17-OHP) and oestriol was studied
using a commercial digoxin assay.
2It was demonstrated that there is high
digoxin-like immunoreactivity in cord blood samples
from newborns without previous maternal or foetal
digoxin treatment. DLIS varied from 0.50 nmol/l to 1.37
nmol/l digoxin equivalent and the mean was 0.91 nmol/l.
When cord blood was heated (5 min at 1000C), the
digoxin-like immunoreactivity increased by a mean of
2.3 times. This suggests that DLIS is present in serum
in the form of free and bound fractions. The bound
fraction is readily dissociated by heating.
Significant correlation between digoxin-like
immunoreactivity and the combined effect of steroid
hormones was found. It was found that about 68% of the
observed digoxin-like immunoreactivity could be
explained by the presence of high concentration of
steroid hormones in cord blood.
Progesterone was found to nave the nignest
cross-reactivity of 0.0067%. The potency of cross-
reactivity in the RIA kit was found to be in the order
of progesterone, androstenedione, 17-OHP, cortisol,
DHEAS, oest.radiol and oestriol. Oestradiol and oestriol
had the least cross-reactivity of 0.0002%.
Cord blood samples were also assayed for
their ATPase inhibitory levels. A mean value of 26.1
3nmol/l ouabain equivalent was found. The ATPase
inhibitory properties of the steroids were also
studied. In the assay for [Na+, K+] -ATPase inhibition
study, progesterone was found to be the strongest
inhibitor followed by androstenedione, DHEAS, cortisol,
oestradiol and oestriol. 17-OHP did not have ATPase
inhibitory action even at millimolar concentration.
Overall there was lack of correlation between
the biochemical and immunological properties of the
steroids as DLIS. Although progesterone showed the
highest cross reactivity with the digoxin antibody and,
ATPase inhibitory activity, however, its contribution
to the digoxin-like immunoreactivity in cord blood was
found to be 2-14%.
Although steroids were demonstrated to cross-
react with digoxin antibody and inhibit ATPase activity
to some degree, their concentrations in plasma cannot
totally account for concentration of DLIS in cord
blood. Simulated serum cocktails failed to give a
comparable digoxin cross-reactivity compared to the
corresponding cord blood with similar steroid
concentrations. They also failed to inhibit ATPase
activity. Preliminary evidence suggests that DLIS
immunoreactivity may not be due to the elevation of
major known steroids in cord blood.
42. REVIEW
2.1 Chemical nature of digoxin
Digoxin is one of the digitalis compounds
(cardiac glycosides) which have a characteristic ring
structure (aglycone or genin) to which is coupled one
or more sugars. The aglycone portion of the glycoside
consists of a steroid nucleus and an lactone ring at
C17 position of the steroid nucleus. The hydroxyl group
at C3 and C14 are in R-configuration. The sugars are
attached usually through the C3 hydroxyl group. Digoxin
has three sugar residues attached at C3 position.
(Figures la and ib)
2.2 Use of Digoxin
Digoxin can influence the contractility of
myocardial muscular tissue (inotropic action) and
affect the rate of rhythmic movement such as heart beat
(chronotropic action). It is commonly used in the
treatment of cardiac failure. It enhances the
contractility of myocardial tissue so as to improve the
pumping function of the heart. It is also used as an
anti-arrhythmic agent for atrial fibrillation and
flutter. The mechanism of action of digoxin is through
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6its inhibitory action on the [Na+, K+] -adenosine
triphosphatase (ATPase) (EC 3.6.1.37) transmembrane
pump of the sarcolemma [1]. The inhibition results in
the accumulation of intracellular sodium ions, which is
thought to cause displacement of bound calcium ions.
The resulting high calcium ions available to
contractile elements cause a positive inotropic effect,
resulting in more forceful contraction of the
myocardium [2].
2.3 Therapeut.c ma.n..tor..ng...... af d.gox.n
There is a marked variation in the individual
sensitivity to digoxin. The effective dosage of digoxin
treatment in congestive cardiac failure and the plasma
level at which toxicity occurs among individuals may be
different [3]. Moreover, there is substantial overlap
between the currently defined therapeutic range and
toxic concentration. Therefore, appropriate therapeutic
goals should be chosen with care when digoxin is used.
Many immunoassays have been developed and marketed for
the measurement of digoxin level in patients in order
to monitor the plasma. level and to detect toxic plasma
concentration (above 3.2 nmol/1).
72.4 Digoxin measurements
Historically digoxin assays are of two types:
those using [Na+.K+]-ATPase inhibition and those using
immunoassays with antibodies raised against digoxin.
2.4.1 ATPase-based assays
since aigoxin is xnown to inhibit ATPase
activity, digoxin can be measured by i) the measurment
of ouabain sensitive ATPase inhibition, ii) competition
for digitalis receptor [4] and iii) the rate of cation
transport [5]. Using cells and tissue, one can measure
cation transport by monitoring either 86rubidium [86Ru]
influx or 2 2 sodium [2 2 Na] efflux. These non-specific
methods for the quantitation of digoxin were not
explored further and eventually abandoned.
2.4.2 rmmunoas.s a.Ys.
With the development and introduction of the
immunoassays, digoxin measurement by radioimmunoassay
(RIA), enzyme immunoassay (EIA) and fluorescence
immunoassay (FIA) have become popular. There are
several commercial and-non-commercial digoxin
immunoassays available which are claimed to be
relatively specific [6]. The digoxin concentrations
measured in plasma or serum usually yield varying
results with different immunoassays [7]. Cross-
8reactivity and interference with structurally related
steroids and other cardioglycosides are stated for most
commercial antisera (eg. Table 1 shows cross-
reactivities for one of the commercial (RIANEN) digoxin
kit). Antibodies used in these assays are raised
against a conjugate of bovine albumin and digoxin,
which is prepared by coupling linkage through the
carbohydrate moiety of digoxin. The antibodies
generated against this conjugate are directed against
the steroid moiety of digoxin [8] and therefore may
cross-react with other related steroids.
2.4.3 Known substances interfering in ATPase assay
and digoxin RIA
It was demonstrated that endogenous lipids
and fatty acids could inhibit ATPase activity [9,10].
Unsaturated fatty acids [11] and lysophospholipids [10]
had been reported to be immunoreactive with anti-
digoxin antibodies and also inhibited [Na+,K+]-ATPase.
It was demonstrated by Lau and Valdes that in the
presence of protein, the ATPase inhibitory activity and
interaction with the anti-digoxin antibody were
virtually eliminated [12].
Moreover, [Na+, K+] -ATPase is very sensitive
to intracellular sodium, and therefore substances
including thyroxine [13] and aldosterone [14] that





















alter internal sodium level can interfere with the
accuracy in measurement of cation transport.
In addition to the steroids that might cross-
react with the anti-digoxin antibody, digoxigenin bis-
and mono-digitosixide and digoxigenin itself all react
with the antibodies, whereas dihydrodigoxigenin and
dihydrodigoxin metabolites in which the C22 is reduced
show little cross reactivity [8].
2.5
Digoxin-like immunoreactivity in clinical settings
Plasma from normal subjects who are not on
digoxin therapy has been shown to modestly inhibit
ATPase activity [3]. In the mid sixties, when digoxin
levels were measured by the inhibition of 86rubidium
uptake by human erythrocytes, false positive results
were found in patients who had not taken digitalis
compounds or other drugs known to interfere in the
assay [5]. With some of the commercial immunoassay
kits, false positive digoxin levels have been reported
in renal failure patients who are not taking digoxin
[15]. Similar false positive observations have also
been reported in patients with liver impairment [16],
in pregnancy [17], in hypertension [18], in amniotic
fluid [71 and in cord blood[ 17]. Digoxin like
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immunoreactivity observed in these studies can be due
to either a specific compound or non-specific
interference in the assay.
2.6 Presence of digoxin-like immunoreactive substance
(DLIS)
The evidence for the presence of endogenous
DLIS is supported by the studies on a circulating
natriuretic factor involved in salt and fluid volume
regulation [19]. This factor, termed third factor or
natriuretic factor, has been extensively studied over
the past two decades. Digoxin like immunoreactivity by
RIA method was shown to be increased in a digoxin free
animal when the extracellular fluid volume was expanded
by saline infusion [20]. The factor has been partially
purified by HPLC and it shows parallel antibody
displacement responses in the RIA when compared with
digoxin. The supposed natriuretic hormone has been
isolated from plasma[ 21], placenta [22] and brain
[23]. It cross reacts with digoxin antibody, inhibits
[Na+, K+] -ATPase, and also causes natriuresis and
diuresis [24].
Implications of digoxin-like immunoreactivity2.7
The above observations have raised two
12
important issues related to the presence of digoxin-
like immunoreactivity in human beings. One is the
detrimental impact on the accuracy of digoxin
measurement and the other is its patho-physiological
implications.
2.7.1 Interference with digoxin measurement
Digoxin is routinely measured in serum or
plasma by immunoassays. The therapeutic range for
patients on digoxin treatment is 1.0-2.6 nmol/l. This
narrow therapeutic range places rigorous demands on the
accuracy and reproducibility of digoxin assays.
Presence of DLIS in patients with renal failure, liver
impairment, pregnancy and newborn infants makes the
interpretation of plasma level difficult.
2.7.2 Patho-physiological implications
If the DLIS is a specific substance, it may
have potential patho-physiological importance in renal
failure, hepatic failure, newborn infants and
pregnancy. The putative action of DLIS is to inhibit
sodium transport by decreasing [Na+,K+]-ATPase activity
and cause natriuresis. Patients with essential
hypertension, renal failure, newborn infants and
pregnant women are volume expanded. Therefore, the
increase in DLIS in these patients may be linked to
13
volume expansion. It may also be involved in other salt
and volume derangements.
It was reported that the concentration of
DLIS in plasma more than doubled in response to both an
intravenous salt load and a high-salt diet in patients
with mild hypertension [25]. Correlation between the
concentration of [Na+,K+] ATPase inhibitor in plasma
and the mean atrial blood pressure of the normotensive
and hypertensive individuals has also been demonstrated
[26]. The physiological relevance of DLIS and its
detection in other clinical conditions is the subject
of research in the study of hypertension, salt and
fluid regulation.
It has been suggested that DLIS is
synthesized by the foetal-placental unit. This view is
supported by i) high maternal serum concentration of
DLIS in pregnancy, ii) production of DLIS decreases
after birth as the foetal-adrenal glands start to
involute [27], and iii) the identification of DLIS in
human placental homogenates. However, there is a
diverse range of substances yet to be identified as a
modulator of the physiological reponses in hypertension
of fluid homeostasis.
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3. OBJECTIVE OF PROJECT
The cross reactivity of steroids and digoxin
metabolites with the anti-digoxin antibody is well
known and is usually stated for most commercial
antisera. There are several explanations for these
cross-reactions, but the two pertinent reasons are:
firstly, the falsely high level of digoxin measurement
is due to non-specific interference. Secondly, the
falsely high level of digoxin measurement is due to the
structurally related steroids or DLIS which react
directly with the specific anti-digoxin antibodies.
Some compounds eg. lipids, fatty acids and
proteins do not cross-react but nevertheless affect the
radioimmunoassay (RIA) results by sequestering labelled
digoxin to yield false-positive results. Organic
solvents, pH, ions and proteins affect antibody binding
in many radioimmunoassays. To distinguish between the
specific and non-specific interferences in an antigen-
antibody system is difficult. But usually, though not
universally true, a parallel response with calculated
degree of displacement can be used as a marker for the
contribution of a specific interference.
While the conjugate is prepared by the
15
linkage through the carbohydrate moiety of digoxin to
the bovine serum albumin, antibodies raised against
this digoxin conjugate are directed mostly against the
steroid moiety. As a result, cross reaction of the
digoxin metabolites and many related steroids with, the
anti-digoxin antibody may be expected.
Although an endogenous DLIS has yet to be
isolated and characterized, some steroid hormones or
their intermediates have been proposed as likely
candidates. The interactions of some common steroid
hormones and intermediates which are raised in foetal
cord blood, with the rabbit anti-digoxin antibodies are
studied in an attempt to demonstrate if they could
account for the falsely high level of digoxin-like
immunoreactivity in the cord blood. The objectives of
this project are:-
1. To measure the digoxin immunoreactivity of cord
blood samples.
2. To study heat stability of DLIS as one of the
physical properties of DLIS.
3. To study the concentration of steroids in cord
blood and to see if this correlates with DLIS.
4. To examine the cross reactivity of steroids in
digoxin radioimmunoassay.
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5. To study the LNa+, K+] -ATPase inhibitory activity
of cord blood extracts-
6. To study the inhibition of [Na+, K+] -ATPase by
steroids.
17
4. MATERIALS AND METHODS
4.1 Materials
4.1.1 D .gox n RIIA...k is
Digoxin RIA kits were obtained from Nev
England Nuclear (NEN), North Billerica, MA, USA
4.1.2 Steroid RIA kits
RIA coat-a-count kits for cortisol,
oestradiol, progesterone, DHEAS, androstenedione, 17-
OHP, total and free oestriol were obtained from
Diagnostic Products Corporation (DPC), Los Angeles, USA
4.1.3 Chem.cals
Cortisol, oestradiol, progesterone, DHEAS,
androstenedione, 17-OHP, ouabain, adenosine 5'-
triphosphate (sodium salt), dog kidney ATPase,
phosphoenolpyruvate pyruvate kinase/lactate
dehydrogenase, NADH, tris(hydroxymethyl)methylamine
were obtained from Sigma Chemical Co., St. Louise, USA.
Activated charcoal, sodium chloride, magnesium
sulphate, ethylenediaminotetra-acetic acid disodium
salt (EDTA), 1,2-di(2-aminoethoxy)ethane-NNN'N-tetra-
acetic acid (EGTA), N-tris(hydroxymethly)methyl-2-
amino-ethanesulphonic acid (TES) and methanol were
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obtained from British Drug House (BDH), Dorset,
England. Sep-pak C18 cartridges were obtained from
Waters Associates, Milford, Massachusetts, USA. Tri-
level ligand control sera were obtained from Ciba-
Corning Diagnostic Corp., USA.
4.1.4 Collection of blood samples
10-15 ml of cord blood was drawn from the
umbilical cords of 29 neonates delivered vaginally.
Blood was taken from the placental end of the cord
after delivery. All were full term deliveries and none
of the women were on digoxin therapy. The blood sample
was allowed to clot by standing at room temperature for
2 hours. The blood was centrifuged at 1,800g for 5
minutes in a Beckman TJ-6 centrifuge and the serum was
dispensed into 1 ml aliquots and stored at -30°C until
assay.
Clotted blood was obtained from the Red Cross
Blood Transfusion Centre and the sera pooled,
irrespective of sex and age. They were used for the




The [123I] tracer is carried by histamine
which is coupled to the terminal sugar of the
tridigitoxose moiety. This tracer is claimed to exhibit
high immunoreactivity and stability. The digoxin
antibody was raised in rabbit and was pre-reacted with
an antiserum to rabbit gamma globulin in phosphate
buffer.
The recommended procedure was followed except
the volume of the standards, samples, control serum,
tracer and antiserum complex were reduced to 2/5 for
sake of economy. This did not affect the accuracy and
precision of the assay (Ho CS, personal communication).
All standards and samples were assayed in duplicate and
the mean values were taken. Duplicates with variation
greater than 10% were repeated.
4.2.2 Radioimmunoassays of steroids
RIA for cortisol, oestradiol, progesterone,
DHEAS, androstenedione, total and free oestriol and 17-
OHP were performed essentially according to the
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manufacturer's recommended nrocedure.
Briefly in these assays, the immobilized
antibody reacted with [125I]-labelled tracer and
unlabelled analyte for a period of time. At the end of
the incubation period, the supernatant containing
unreacted analyte was aspirated and the amount of label
bound to the antibody was counted in a gamma counter.
All standards, controls and cord blood samples were
assayed in duplicate.
As the concentrations of steroids in cord
blood were expected to be high, cord blood sera were









In the androstenedione assay serum samples
were extracted with diethyl ether prior to assay. The
extract was redissolved in buffer (zero calibrator)
After evanoratinq the ether in a vacuum oven.
Both free and conjugated oestriol were
measured in the determination of total oestriol. This
was done by simultaneous incubation of tracer-enzyme
solution which was freshly prepared by mixing the
tracer solution with enzyme solution containing
glucuronidase and sulphatase prior to assay.
4.2.3 £.Na+ KM-ATPase Inhibition Assay
ATPase activity was assessed by an











The ADP generated by ATPase reaction was used
for the formation of pyruvate in the presence of
phosphoenolpyruvate and pyruvate kinase. Lactate
dehydrogenase then converts the pyruvate into lactate
at the expense of NADH. The ATPase activity is
therefore related to the decrease in NADH concentration
ie. the decrease of absorbsnos at o40 nm.
4.2.3.1 Reagents for preincubation
1. Incubation buffer
100 mM NaCI, 4 mM MgSCU and 0.5 mM EDTA in 50
mM Tris buffer pH 7.4
2. Adenosine 5'-triphosphate solution
5 mM Adenosine 5'-triphosphate, sodium salt
in the incubation buffer
3. [NafK]-Adenosine 5'-triphosphatase solution
5 U of dog kidney [Na,K] ATPase was dissolved
in 1 ml of 10 mM Tris buffer containing 0.5
mM EDTA. This stock solution was separated
into 50 pi aliquots and kept at -70°C until
use. 950 pi of incubation buffer was added to
the 50 pi [Na,K] ATPase stock aliquot before
use.
4. Calibration standards
5, 10, 20, 30, 50, 70 nM ouabain standards
were prepared in incubation buffer.
4.2.3.2 Reagent for [Na,K]-ATPase activity assay :-
1. 128 mM TES-Tris buffer pH7.4
2. Na-K solution
107 mM KC1, 533 mM NaCI, 32 mM MgS04 and 27
mM EGTA in 128 mM TES-Tris buffer pH 7.4
3. Adenosine 5'-triphosphate (ATP) solution
96 mM Adenosine 5'-triphosphate (sodium salt)
in 128 mM TES-Tris buffer pH 7.4
4. Phosphoenolpyruvate (PEP) solution
38 mM Phosphoenolpyruvate in 128 mM TES-Tris
buffer pH 7.4
5. PK-LD solution
55 pi of pyruvate kinaselactate
dehydrogenase solution was diluted to 1 ml
with 128 mM TES-Tris buffer pH 7.4
6. NADH solution
18 mM MADE in 128 mM TES-Tris buffer pH 7.4
7. Working solution
The following working solution was prepared












1. Sep-pak Cia cartridge was pre-wetted with 2
ml of methanol and then washed with 10 ml of
distilled water.
2 200 pi of cord serum sample was injected at
one end of the cartridge and it was allowed
to stand for 3 minutes.
3. 20 ml of distilled water in syringe was
puraped through the cartridge to wash away the
high polarity compounds.
4. Low polarity compounds were eluted with 2 ml
of methanol and the eluate was collected in
an Eppendorf tube. (Sep-pak Ci e cartridge was
then washed with 20 ml of distilled water for
reuse. Each cartridge was used for the
preparation of five cord serum samples.)
5. The eluates were evaporated to dryness under
negative pressure at 40°C.
6. Once dry, the residue was resuspended in 200
pi of incubation buffer and vortex mixed.
7. 100 pi each of ouabain standards or serum
sample extracts, 50 pi ATP solution and 50 pi
of [Na,K] ATPase solution were added to an
Eppendorf tube, vortex mixed and incubated at
37°C for 2 hours.
8. After incubation, the above solution was
transferred to a Cobas-Bio centrifugal
analyzer. The enzyme reaction was started by
the addition of working solution mixture of
reagent 7. The absorbance at 340 nm was
followed kinetically.
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10. The inhibition caused by the unknown was
determined from the calibration curve and
expressed as ouabain equivalent.
4.2.4 Preparation of steroid freeserum
10 g of activated charcoal was added to 200
ml of serum, and the contents were stirred with a
magnetic stirrer for 2 hours at 4°C. The serum was
centrifuged at 4500 rpm (7,000g) in a Beckman J-6B
centrifuge at 4°C for 15 minutes. The supernatant was
removed and passed through 0.45 urn Millipore filter.
The concentration of digoxin and steroids of interest
were measured in the pooled serum before and after the
charcoal treatment.
4.2.5 Precision and detection limit
The detection limit of digoxin RIA was
studied by analyzing ten samples of zero calibrator
obtained from RIANEN (New England Nuclear, North
Billerica, MA, USA). The value of mean+2SD was taken
the sensitivity of digoxin assay based on 95%
confidence limit.
Precision of the ATPase inhibition method was
determined by eight analysis of a pooled cord blood
serum samples. Cord blood sera were prepared by passing
through the Sep-pak Cie cartridge. The methanol eluates
were assayed for the ATPase inhibition. The value of
eight separate runs of the pooled serum were used for
the calculaton of inter-assay precision of the [Na,K]
ATPase assay.
Inter-assay precisions of Cortisol,
oestradiol and progesterone radioimmunoassays were
determined by multiple analysis of Ciba-Corning Tri-
level Ligand Control sera A, B and C. Each control
sample was analyzed in twelve separate assays for
Cortisol and estradiol, and eleven times for
progesterone. Single level control serum was provided
with the digoxin assay kit was assayed in nine separate
runs. The coefficients of variation (CV) were






4.2.6 Efect of heating on digoxin-like
immunoreactivity and steroid levels
Cord blood sera and charcoal treated pooled
serum were diluted 1:3 with deionised water, and heated
at 100°C for 5 minutes in a boiling water bath. Water
was used to decrease the ionic strength and protein
concentration of the serum samples to prevent protein
coagulation upon heating [28]. Heated sera were allowed
to cool and then assayed for digoxin, oestradiol and
cortisol levels on the same day.
4.2.7 Cross reactivity of steroids in digoxin RIA
Since all steroids studied are naturally
occurring intermediates in human serum, they may
contribute to the digoxin-like immunoreactivities
observed in newborns and pregnant women. The cross
reactivity of cortisol, oestradiol, progesterone, 17-
OHP, androstenedione, DHEAS and oestriol were examined.
In order to simulate the physiological state
of the steroids measured and to preserve the matrix
integrity for immunoassay, a stock solution of steroids
dissolved in methanol were diluted serially in steroid
free serum. These were then assayed for DLIS using the
digoxin RIANEN kit. The percentage binding of digoxin
was plotted against the concentration of the competing
steroid. The respective dose response curve is compared
against the standard curve of digoxin.
The concentration of the steroid causing 50%
displacement (Ds o ) of digoxin tracer was used to
determine percentage cross reactivity. The cross
reactivity of steroids was calculated by dividing the
Ds 0 (molar) value of digoxin by the Ds0 (molar) value
of the respective steroid and was expressed as a
percentage.
Cross reactivity
Ds0 of Digoxin (molar)
Ds0 of steroid (molar)
X 100%
4.2.3 Digoxin immun.or eac t i.y i.ty and ATP as e
inhi b i tor y r eac t i v i ty of s imu la ted cord... bl 0 od
samples.
Four serum samples were prepared by adding
various concentrations of steroids to steroid free
serum to mimic cord blood samples. Four typical cord
blood samples that had a high DLIS level (sample C43),
intermediate level (samples C31 and C4 8) and Ioa' level
(sample C14) were selected. These four samples also had
a higher concentration of progesterone. The
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concentration of cortisol, oestradiol, DHEAS,
progesterone, 17-OHP, androstenedione and free oestriol
in these samples were obtained and stock solution of
steroids were added to charcoal treated pooled serum to
simulate the four cord blood samples and they were
labelled S14, S31, S43 and S48.
Four additional samples were prepared based
on the calculated mean concentrations of steroids in
the 29 cord bloods analyzed. Sample A had the steroid
concentrations at 2SD above the means. Sample C had the
steroid concentrations similar to their mean
concentrations in the cord blood. The steroid
concentrations of samples B and D were half those of
samples A and C respectively.
All the simulated cord blood samples were
assayed for digoxin-like immunoreactivity before and
after Sep-pak C18 chromatography. Their ATPase
inhibitory activities were also studied.
4-2-9 Inhibiton of[Na+,K+]-ATPast by steroids
The same series of steroids mentioned in
section 4.2.2 were assayed for their ability to inhibit
ATPase. Serial dilutions of the steroids were made in
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50mM tris buffer pH 7.4. They were then assayed
directly by incubation with dog kidney ATPase for 2
hours at 37°C. The residual ATPase activity was then
assayed on the Cobas-Bio centrifugal analyzer by the
coupled reaction mentioned before.
4.2.10 Procedure for calculation of unknown digoxin
and steroid concentrations in RIA
The net counts for each set of standards and
samples were obtained by subtracting from each the
average background and non-specific binding counts. The
counts were then averaged for each set of duplicate and
they were expressed as a percentage of the average net
count for the zero standard (where B=average net count
of samples, Bo =average net count of zero standard).
average net count of standard or sample
%100% B/Bo
mt7nraPtC:h nPt rnun of zero standard
Logit-log plot with %B/Bo against
concentration for each standard was plotted. The
concentration of samples and controls were determined
by intrapolation from the standard curve.
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4.2.11 Statistical analysis
The difference between digoxin-like
immunoreactivity before and after heating test were
determined by Student's t-test for paired results.
The relationship between digoxin-like
immunoreactivity and the steroids was determined by
linear regression analysis. The correlation coefficient
measured the extent of association between the digoxin-
like immunoreactivity and steroid concentration.
The multiple correlation between digoxin-like
immunoreactivity and the combined effect of steroids
were studied by multilDle linear regression analysis.
The test of the significance of multiple
correlation was studied by the analysis of variance
methods using F distribution test.
Linear regression analysis and multiple
linear regresssion analysis were done using computing
software Abstat Release 3.01 (Anderson-Bell Co.,USA).




5.1 Precision and detection limit of assays
Inter-assay precision of the
radioimmunoassays represented as coefficient of
variation (CV) are shown in Table 2. Highest CV was
found in the assay of progesterone. The CV varied from
9.4% to 13.3%. Digoxin assay had a CV of 4.4% showing a
good precision of the digoxin RIA.
The detection limit of the RIANEN digoxin
assay was found to be 0.13 nmol/l.
5.2 DLIS in cord blood blood samples.
29 cord blood samples were analyzed for the
digoxin level using the digoxin radioimmunoassay. The
mean level of DLIS was found to be 0.91 nmol/1 (range
0.50-1.37 nmol/l) (Figure 2).
Table 2
Precision of radioimmunoassay for the digoxin
and steroid assays













































































































































Figure 2. DLIS level in cord blood before an
after heating
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5.3 Effect of heating on DLIS and steroid levels in
cord blood
The heat treated serum samples yielaea even
higher DLIS level with a mean of 2.02 nmol/l (range
1.567-2.28 nmol/1) (Figure 2). The mean rise in DLIS
level compared to unheated samples was 2.3 times (range
1.6 to 3.1).
Figure 3 shows the scatter diagram of DLIS
before and after heat treatment. The concentration of
DLIS in the heated samples correlated with that of the
unheated samples (correlation coefficient=0.537,
p<0.01).
The mean concentrations of oestradiol and
cortisol in cord blood samples were 275 nmol/l and 49.6
nmol/l respectively. After heating, the mean
concentrations of oestradiol and cortisol were 243
nmol/l and 44.8 nmol/l respectively. Difference between
the unheated and heated samples were not significant.
Figure 4 shows the scatter diagram for oestradiol and
cortisol before and after heat treatment.
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Figure 3. Correlation between HIS in cord blood
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Figure 4. Correlation between cortisol (panel A)
and oestradiol (panel B) in cord blood
before and after heating
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5.4 Effect of charcoal treatment on serum
concentrations of steroids and DLIS
The concentration of DLIS, steroids and the
ATPase inhibitory activity of the pooled serum before
and after charcoal treatment are shown in table 3.
After charcoal treatment, the serum was virtually free
of steroids. The DLIS level and ATPase inhibition
activity were below the detection limit of the assay.
5.5 Steroid pattern in cord blood
Cortisol, oestradiol, progesterone, 17-OHP,
androstenedione, DHEAS, and estriol were measured in 29
cord blood serum samples by radioimmunoassay (DPC coat-
a-count tubes). The levels of steroids in cord blood
samples are shown in Figure 5 and the mean values and
range are tabulated in Table 4. The individual results
of the steroids are given in the appendix I.
The oestradiol and progesterone level were
particularly high in the cord blood compared with the
adults. Progesterone and total oestriol in cord blood
were found to be 1000-2000 times higher than male adult
level. Progesterone was about 20 times higher than the
luteal phase in the adult female. Oestradiol levels
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Table 3 Concentration of DLIS, steroids and ATPase
inhibitory activity in pooled serum before
and after charcoal treatment
Analytes Fooled Sera Steroid free
serum
Digoxin 0.13 nmol/m 0.13 nmol/ml
Cortisol 341 nmol/1 27.6 nmol/1
Progesterone 1.66 nmol/1 0.3 nmol/1
Oestradiol 117 pmol/1 70 pmol/1
6.30 nmol/1 0.35 nmol/1Androstenedione
4.39 nmol/1 0.3 nmol/117-OHP
35 nmol/135 nmol/1Total Oestriol
3.5 nmol/13.5 nmol/1Free Oestriol




























































Table 4 Concentration of steroids and digoxin-like
immunoreactive substance in cord blood samoles
Analytes N Range Mean
( 1 O Male




















64 - 486 nrnol1 275 nmoll
7.00-92.25 nrnol1 49.7 nmoll
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6.60-21.25 nmoll 13.93 nmoll
4.77-12.27 pmol1 8.52 pmol1
0.11-1.51 prnoll 0.81 pmol1
0.53-1.29 nmoll 0.91 nmoll
138-635 nmoll at 0800h
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were about 200 to 1000 times higher than the adult male
and about 5 times higher than that in luteal phase in
female. The 17-OHP was about 10 times higher than that
in the adult male, while the cortisol and
androstenedione levels were comparable to the adult
level.
5. 6 Corrlation between DLIS and concentration of.
steroids in cord blood
The scatter diagrams of digoxin-like
immunoreactivity (before and after heat treatment)
against the appropriate steroids are shown in Figures
6a-6h.
Statistical analysis (Tables 5a and 5b)
showed significant correlations of DLIS with
progesterone, 17-OHP and oestradiol in the unheated
samples. Heat treatment of cord serum samples yielded
significant correlation between DLIS and progesterone,
androstenedine, 17-OHP and free oestriol.
Although oestradiol correlated with DLIS in
the unheated cord blood, no correlation was found in
the heated sample. On the other hand, androstenedione
showed a significant correlation with the heated
CORTISOL-DLIS
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Figure 6b. Correlation between oestradiol and DLIS
in cord blood before heating (panel A)
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Figure 6c. Correlation between progesterone and
DLIS in cord blood before heating (panel A)
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Figure 6d. Correlation between 17«-hydroxyprogesterone
and DLIS in cord blood before heating
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Figure 6e. Correlation between DHEAS and DLIS
in cord blood before heating (panel A)
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Figure 6f. Correlation between androstenedione
and DLIS in cord blood before heating
(panel A) and after heating (panel B)
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Table 5a Pairwise correlation of digoxin-like immunoreactivity against the
concentrations of cortisol, oestradiol, DHEAS, progesterone, 17-OHP,
androstenedione and oestriol (total free) in cord blood serum
before heating
Significance
Steroids Correlation N Coefficients
Level
Progesterone 0.534 29 0.01)p0.001
Oestradiol 0.521 29 0.01)p>0.001
17-OHP 0.430 29 0.02)p)0.01
Cortisol 0.286 29 p>0.1
Androstenedione 0.281 24 p>0.1
Total Oestriol 0.265 29 p0.1
Free Oestriol 0.218 29 p>0.1
-0.187DHEAS 29 p>0.1
Pairwise correlation of digoxin-like immunoreactivity against theTable 5b
concentrations of cortisol, oestradiol, DHEAS, progesterone, 17-OHP,













digoxin-like immunoreactivity but not with the unheated
one.
Correlation between DLIS and cortisol, DHEAS
or total oestriol in cord blood before and after heat
treatment were not sicinificant
There was a negative correlation between
DHEAS and DLIS but this was not statistically
significant.
Multiple regression analysis of the digoxin
like immunoreactivity with the steroids determined
yielded a multiple correlation coefficient of 0.824. By
the analysis of variance, the combined effect of the
steroids included had a significant correlation with
the measured digoxin level in cord blood. 68% of the
observed variation in DLIS in cord blood could be
explained by the combined effect of the steroids
(R2=0.679). As shown in Table 6a, oestradiol,
progesterone and 17-OHP are relatively important in
explaining the level of digoxin-like immunoreactivity
with their partial correlation coefficient of 0.628,
0.523 and 0.422 respectively. The highest standardized
partial regression coefficient of 1.147 was obtained
between oestradiol and digoxin-like immunoreactivity.
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Table 6a Partial multiple linear regression coefficients for digorin-like
immunoreactivity in respect of cortisol, oestradiol, progesterone,
17-OHP, DHEAS, androstenedione and oestriol (total free) levels











Free Oestriol 0.148 0.011
Multiple correlation coefficient= 0.824
F(8,15)= 3.96 0.01 c p( 0.05
Intercept= 0.894
Partial multiple linear regression coefficient for digoxin-likeTable 6b
immunoreactivity after heating in respect of cortisol, oestradiol,














Multiple correlation coefficient= 0.715
0.05 <p< 0.2F(8,15)= 1.96
Intercept= 1.807
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After heating the correlation between the
combined effect of steroids and digoxin-like
immunoreactivity failed to reach statistical
significance (Table 6b).
5.7 Cross reactibity of steroids in diqpxin
radioimmunoassay
The respective 50% displacement (D5o) of the
labelled digoxin by the steroids were determined from
the dose response curves (Figures 7a-7c) and the
results are tabulated in Table 7. 17-OHP and cortisol
had almost similar Doo values of 1.2X10-4M and 15X10-4M
respectively. Progesterone and androstenedione were
about ten fold more potent in displacing 50% of
labelled digoxin. The No of progesterone and
androstenedione were 4.5X10-5 M and 8X10-5 M
respectively. DHEAS had a No value of 2X10-3 M. Due to
insolubility of oestriol and oestradiol, the 50%
displacement of digoxin tracer could not be achieved,
and therefore neither No nor percentage cross
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Figure 7a. Apparent displacement of [ I]-digoxin from
anti-digoxin antibody (RIANEN) by progesterone
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Figure 7b. Apparent displacement of [ I]-digoxin from
anti-aigoxin antibody (RIANEN) by Cortisol (panel A)
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Figure 7c. Apparent displacement of [ I]-digoxin from
anti-digoxin antibody (RIANEN) by androstenedione
(panel A), oestradiol and oestriol (panel B)
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Table 7 Concentration of the steroid causing 50%
displacement of digoxin and their percentage
cross-reactivity with digoxin antibody
Analytes D5 o (molar) Cross Reactivity(%)
Digoxin 1003 X 10-9








5.8 Inhibition of [Na+ K] -ATPase by cord blood
samples
The inter-assay coefficient of variation of
[Na+,K+]-ATPase inhibition assay was found to be 12.6%
(n=8).
Figure 8 gives the results of the [Na+, K+]-
ATPase inhibition expressed as ouabain equivalent in
nmol/1. The mean value was found to be 26.1 nmol/1 with
the range 3.4- 48.8 nmol/l.
5.9 Correlation of digoxin-like immunoreactivity and
[Na+,K+]-ATPase inhibition activity
There was no significant correlation between
the DLIS level and the ATPase inhibition activity for
the cord blood samples. Heat treatment of cord blood
sera yielded a negative correlation between digoxin-
like immunoreactivity and ATPase inhibition activity











Figure 8. ATPase inhibition by the cord blood
extracts expressed as ouabain equivalent
(nmol/1)
ATPase Inhibition-DLIS
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Figure 9. Correlation between ATPase inhibition
and DLIS before heating (panel A) and
after heating (panel B)
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5.10 Apparent inhibition of [Na+K+]-ATPase by the
steroids
Progesterone had the highest inhibition of
the ATPase among the steroids tested (Figure 10).
However, the inhibition was not apparent at
progesterone concentration below 10-5 M.
Androstenedione and DHEAS were the next most potent
inhibitors of ATPase. Oestradiol, cortisol, Oestriol
and 17-OHP had negligible inhibitory action even at
millimolar concentration.
5.11 Diqoxin immunoreactivity and ATPase inhibitory
activity of simulated cord blood samples
The results of apparent digoxin level of the
simulated sera before and after Sep-pak Cis
chromatography are shown in Table 8. Digoxin level of
the in vitro prepared serum sample gave a low digoxin
level. Inhibitory activity of the simulated sera were
not detected although their steroid concentrations were
comparable to each corresponding sample. Sample A, B, C
and D. which covered the full range of steroids in the
cord blood samples gave a low measurable level of DLIS
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Figure 10. Apparent inhibition of [Na ,K ]-ATPase by progesterone,
androstenedione, DHEAS (panel A), Cortisol, oestradiol,
oestriol and 17-OHP (panel B)
Table Apparent digoxin and steroid concentrations in four cord blood
samples, the effect of in vitro simulation of the respective cord
blood serum sarnies































































































































































Using different commercial immunoassay kits,
falsely high digoxin level have been reported in
neonates [30], pregnant women [17], patients with renal
failure [9] and hypertension [18]. This may be
attributed to the variations in antibody specificity
[31] or the non-specific matrix effect [32].
Different reports have shown that the assay
conditions such as the incubation time, antibody
concentration and the amount of tracer can also affect
the cross reactivity of digoxin immunoassay kit. By
modification of the standard assay procedure for
digoxin, the relative cross reactivity can be altered.
It was reported that a sequential RIA analysis could
reduce the cross reactivity by 20-60% relative to the
standard equilibrium RIA procedure in NML kit (Nuclear
Medical Laboratory, Irvine, USA). It was lowered even
further by reducing the antiserum and tracer
concentration [31]. In another assay, prolonging the
incubation time and increasing the incubation
temperature after addition of serum, labelled tracer
and antiserum also reduced the interference [33].
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It was demonstrated by Ho and Swaminathan
that the digoxin assay could be made more sensitive for
DLIS by varying the sample volume, tracer volume and
antibody concentration. In doing so the sensitivity for
digoxin was found to be reduced [34]. In this study,
the recommended procedure of RIANEN kit was followed
because it was demonstrated to have a higher detection
sensitivity for DLIS.
High concentration of digoxin-like
immunoreactivity was found in cord blood samples of
newborn babies who had neither received any digoxin,
nor had their mothers been on digoxin therapy. An
average digoxin value was found to be 0.91 nmol/1 with
the range of 0.50-1.37 nmol/l in cord blood. These
findings confirm the observations of Valdes Graves
[7].
The treatment of serum samples before the
assay can also profoundly affect the results of
analysis. The heat treated (5 min at 100°C) serum
samples yielded a higher level of digoxin-like
immunoreactivity with a mean value of 2.02 nmol/l. The
ratio between heated and unheated values varied from
1.6 to 3.1 with an average of 2.3. The increase in
digoxin-like immunoreactivity after heat treatment can
be due to the release of more interfering substances.
These interfering substances may be non-specific
substances that either sequester labelled digoxin to
yield a falsely high digoxin level or bind to the
digoxin antibody.
The finding of a higher level of digoxin-like
immunoreactivity after heat treatment can also be due
to the release of a specific DLIS. It is consistent
with the hypothesis that DLIS is protein bound though
not covalently. The bound DLIS are not readily released
until the protein is denatured or after extensive
dialysis [28]. In the study of heat treatment of
oestradiol and Cortisol, the assay value of these
steroids did not change after heating because in these
assays (direct assay), protein bound steroids are
completely displaced by agents such as 8-anilino
sulphonic acid. This suggests that DLIS is different
from substances like oestradiol and Cortisol in its
properties of protein binding. At least the proportion
of bound and free fraction of DLIS are certainly
different from other known steroids.
In view of the steroidal nature of digoxin,
it is tempting to attribute part of the the digoxin-
like immunoreactivity in cord blood sample to high
level of steroid hormones and intermediates [10].
Correlation study showed that there was
significant correlation between progesterone, 17-OHP,
oestradiol and digoxin-like immunoreactivity in cord
blood. Significant correlation was also found between
the DLIS in heat treated cord sera and progesterone,
17-OHP, androstenedione and free oestriol. There was no
correlation between the DLIS and Cortisol, DHEAS or
total oestriol in cord blood.
DHEAS [35], progesterone and its derivatives
[36] have been reported as possible candidates for DLIS
in the plasma of healthy adults. DHEAS was demonstrated
to account for 62-100% of the total DLIS in plasma of
the eleven healthy adults by Vasdev et al [35].
However, the present study showed that there was no
significant correlation between concentration of DHEAS
and digoxin-like immunoreactivity in cord blood. Using
the same RIANEN digoxin kit as we used, the
concentration of DLIS in healthy adults was found to be
36-53 pmol1 by Vasdev et al [35]. The concentration of
DLIS in normal adults was far below the detection limit
(0.13 nmol1) of RIANEN digoxin kit in this study.
There was no mention how the low detection limit was
achieved. Unlike the situation in normal adults, the
contribution of DHEAS to digoxin-like immunoreactivity
in cord blood is found to be insignificant. This is
consistent with the finding of Lau et al [12] .
From the multiple correlation study, the
combined effect of progesterone, 17-OHP, DHEAS,
androstenedione, Cortisol, oertradiol and oestriol did
contribute significantly to the observed level of DLIS
(R=0.826, n=24) . It might be due to matrix effect of
the steroids in serum sample. The mechanism of the
combined effect of the steroids is not known. These
seven steroids may not per se account for DLIS activity
in the cord blood, complicated mutual conformational or
steric effect on antibody binding is possible.
The steroids included in this study did react
with anti-digoxin antibody and displaced the labelled
digoxin as a function of steroid concentration.
Progesterone was the most potent displacer of [l25 I]-
digoxin, a concentration of 4.5X10-5M caused 50%
displacement of digoxin. It cross-reacted at 5X10~6M.
This is quite similar to the finding of Vinge et al
[37]. Progesterone had the highest cross reactivity
among the steroids (0.0067%). It was two times more
potent than androstenedione (0.0038%), and three times
more potent than 17-OHP (0.0025%) and Cortisol
(0.002%). DHEAS, oestriol and oestradiol had a
negligible cross reactivity at normal physiological
levels in adults. The finding of low cross-reactivities
for the steroids is consistent with the reports of
others [8,38], The concentration of steroid hormones
required to produce a detectable DLI3 level were much
greater than the normal concentration found in normal
adult plasma or cord serum.
In the study of biological activity of the
steroids as inhibitor of ATPase, progesterone was found
to have the highest inhibitory activity. It inhibited
ATPase activity at concentrations of 105M which is
ten times higher than the concentration in the cord
blood and is much above the physiological concentration
in normal adults.
Androstenedione and DHEAS inhibited ATPase at
concentration 10~4M. Cortisol, oestriol, oestradiol
and 17-OHP had negligible ATPase inhibitory activity at
103M concentration.
There appeared to be a parallel relationship
between the cross-reactivity and the ATPase inhibition
for progesterone, androstenedione and DHEAS.
Progesterone was the most potent sueoid m this
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regard, followed by androstenedione and DHEAS.
Progesterone accounted for a mean concentration of 0.17
nmol/l of apparent digoxin level in cord blood measured
by RIANEN kit. An average of 8.27% of the observed
digoxin-like immunoreactivity in cord blood could be
attributed to the presence of progesterone.
Progesterone had also been shown to have the strongest
effect on the [8 6 Ru] uptake among the anaesthetic
progesterone derivatives. It was demonstrated to
decrease [86Ru] by 18% at millimolar concentration
[37].
Reported upper limit of progesterone in the
normal male adult was about 1 nmol/l and it can reach
650 nmol/l in the third trimester of pregnancy in
female [29]. These concentrations in normal adult are
100 times lower than 10-7 M required for the cross-
reactivity to occur and 10,000 times lower than 10-5 M
needed to inhibit the ATPase activity. At normal
physiological concentration of steroids it is unlikely
that they contribute in a significant way to cross-
react with anti-digoxin antibodies and inhibit ATPase
avtibity in vivo.
The serum samples prepared in vitro to
contain steroids at concentrations similar to that in
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cord blood failed to give a detectable level of
digoxin-like immunoreactivity by RIANEN. It may be
argued that there are numerous other steroid
intermediates and metabolites in cord blood, that were
not assayed in the present study, but nevertheless may
contribute to digoxin-like immunoreactivity. Although
the major steroid intermediates in neonates eg. 3p-
hydroxy-5-ene steroids, pregnenolone and pregnanetriol
[38] were not included in the simulated serum, their
contribution to DLIS is considered insignificant.
Pregnanetriol and pregnenolone were demonstrated to
have very low cross-reactivities in RIANEN digoxin kit
[391.
There is lack of correlation between DLIS
level and the ATPase inhibitory activity in cord blood.
Although 85% recovery of DLIS immunoreactivity after
Sep-Pak extraction was reported [40], partial
purification of serum by Sep-Pak cartridges appeared
not to be totally satisfactory for the purification of
DLIS for the ATPase inhibitory test. There are over
hundred compounds known to inhibit ATPase activity
[41]. Some low polarity ATPase inhibitors may remain in
the extract even after Sep-Pak separation. These may
include lipid and some unsaturated fatty acids
[9,10,11]. However, the interfering substances have yet
to be identified.
73
The lack of specificity of present
immunoassays for digoxin is a serious shortcoming for
purpose of therapeutic drug monitoring. It would be
useful to raise more specific antibodies to the
carbohydrate component of the digoxin molecule by
linking the steroid ring to the albumin and exposing
the digitose sugar as the antigenic determinant [8].
47. CONCLUSION
High levels of DLIS were found in cord blood
samples. Heat treatment of cord blood sample yielded
even higher levels of DLIS. This is consistent with the
hypothesis that there are free and bound fractions of
DLIS in serum. The free to bound ratio was found to be
1:1.3 in cord blood.
Cord. blood is rich in steroid hormones.
Progesterone, 17-OHP and oestradiol were found to be
particularly high in cord blood. Progesterone, 17-OHP
digoxin-like immunoreactivity in cord blood. No
correlations were found between DLIS and cortisol,
DHEAS, total oestriol in cord blood.
Although the steroids studied did not total
account for plasma digoxin-like immunoreactivity in
cord blood, the combined effect of the steroids
contributed significantly to the digoxin-like
immunoreactivity. 68% of the observed variation in DLIS
in cord blood could be explained by the combined effe
of the steroids.
and oestradiol had signiflcant correlation with the
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Among the steroids tested progesterone had
the highest cross-reactivity with digoxin antibody and
was the most potent ATPase inhibitor. Progesterone
concentration in the cord blood samples could only
account for 2-14% of the total digoxin like
immunoreactivity. It inhibited ATPase at concentration
10-5M which is 10 times above the concentration in
cord blood and 1,000 times above the concentration in
normal adult.
Simulated serum cocktails containing steroids
at concentrations similar to cord blood did not give a
detectable level of digoxin-like immunoreactivity and
ATPase inhibition. At physiological concentration seen
in normal adults and cord serum, progesterone will have
negligible effect on digoxin radioimmunoassay or ATPase
inhibitory activity. Preliminary evidence suggests that
the elevation of the major steroids only partly
accounts for the level of DLIS in cord blood.
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Appendix I Steroid and DLIS levels of individual cord blood samples
Samples
Cortisol Oestradiol DHEAS Prog Androst 17-OHP Free E3 Total E3 DLIS






















































































































































































































































































































































































































Appendix II Apparent displacement of [1251]™digoxin from anti-digoxin antibody (RIANEN) by steroid hormones
DHEAS


























































Concentration %B of 1251-digoxin
Cortisol


































Concentration %B of 1251-digoxin
3.41 mM
1.70 mM
852 uM
170 uM
34 uM
6.8 uM
1.4 uM
280 nM
9.1
13.8
19.2
37.2
64.7
87
100
100


